A prospective birth cohort study of maternal prenatal cigarette smoking assessed by self-report and biomarkers on childhood risk of overweight or obesity. Issue 3 (7th December 2022)

• Record Type: Journal Article
• Authors: Hou, Wenpin; Zhang, Mingyu; Ji, Yuelong; Hong, Xiumei; Wang, Guoying; Xu, Richard; Liang, Liming; Saria, Suchi; Ji, Hongkai
• Is Part Of: Precision nutrition. Volume 1:Issue 3(2022)
• Page Start: e00017
• Publication Date: 2022-12-07
• Subjects: Maternal prenatal smoking -- Childhood obesity -- Smoking biomarkers -- Cotinine -- Hydroxycotinine -- Plasma -- Cord blood -- In utero exposure; Diet therapy; Nutrition; Personalized medicine; Periodicals; 615.854
• DOI: 10.1097/PN9.0000000000000017
• Languages: English
• ISSNs: 2563-9021

Abstract

Abstract : Background: Most studies on the association of in utero exposure to cigarette smoking and childhood overweight or obesity (OWO) were based on maternal self-reported smoking status, and few were based on objective biomarkers. The concordance of self-report smoking, and maternal and cord blood biomarkers of cigarette smoking as well as their effects on children's long-term risk of overweight and obesity are unclear. Methods: In this study, we analyzed data from 2351 mother-child pairs in the Boston Birth Cohort, a sample of US predominantly Black, indigenous, and people of color (BIPOC) that enrolled children at birth and followed prospectively up to age 18 years. In utero smoking exposure was measured by maternal self-report and by maternal and cord plasma biomarkers of smoking: cotinine and hydroxycotinine. We assessed the individual and joint associations of each smoking exposure measure and maternal OWO with childhood OWO using multinomial logistic regressions. We used nested logistic regressions to investigate the childhood OWO prediction performance when adding maternal and cord plasma biomarkers as input covariates on top of self-reported data. Results: Our results demonstrated that in utero cigarette smoking exposure defined by self-report and by maternal or cord metabolites was consistently associated with increased risk of long-term child OWO. Children with cord hydroxycotinine in the fourth quartile ( vs. first quartile) had 1.66 (95% confidence interval [CI] 1.03–2.66) times the odds for overweight and 1.57 (95% CI 1.05–2.36) times the odds for obesity. The combined effect of maternal OWO and smoking on offspring risk of obesity is 3.66 (95% CI 2.37–5.67) if using self-reported smoking. Adding maternal and cord plasma biomarker information to self-reported data improved the prediction accuracy of long-term child OWO risk. Conclusions: This longitudinal birth cohort study of US BIPOC underscored the role of maternal smoking as an obesogen for offspring OWO risk. Our findings call for public health intervention strategies to focus on maternal smoking – as a highly modifiable target, including smoking cessation and countermeasures (such as optimal nutrition) that may alleviate the increasing obesity burden in the United States and globally.